ICUI - ICU Medical, Inc.
NEXT EARNINGS:
May 14, 2026
EPS Est: $1.78
|
Rev Est: $532.9M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$179.00
DETAILS
HIGH:
$180.00
LOW:
$178.00
MEDIAN:
$179.00
CONSENSUS:
$179.00
UPSIDE:
17.40%
Market Cap:
3.76B
Volume:
297,711
Avg Volume:
237,596
52 Week Range:
107-162.11
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
0.80
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
15,000
IPO Date:
1992-03-31
EPS (TTM):
0.03
P/E Ratio:
4802.44
Revenue (TTM):
2.23B
Total Assets:
4.05B
Total Debt:
1.39B
Cash & Equiv:
307.96M
Rev Growth (5Y):
11.9%
EPS Growth (5Y):
-62.8%
FCF Growth (5Y):
-5.6%
ROCE:
3.0%
Debt/Equity:
0.66
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $1.91 | $1.68 | +13.7% | $540.3M | $521.7M | +3.6% |
| 2025-11-06 | $2.03 | $1.43 | +42.0% | $537.0M | $511.5M | +5.0% |
| 2025-08-07 | $2.10 | $1.44 | +45.8% | $548.9M | $511.5M | +7.3% |
| 2025-05-08 | $1.72 | $1.23 | +39.8% | $604.7M | $603.7M | +0.2% |
| 2025-02-27 | $2.11 | $1.48 | +42.6% | $629.8M | $599.1M | +5.1% |
| 2024-11-12 | $1.59 | $1.25 | +27.2% | $589.1M | $574.6M | +2.5% |
| 2024-08-07 | $1.56 | $0.98 | +59.2% | $596.5M | $553.7M | +7.7% |
| 2024-05-07 | $0.96 | $0.84 | +14.3% | $566.0M | $552.2M | +2.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.23B | 2.38B | 2.26B | 2.28B | 1.32B | 1.27B | 1.27B | 1.40B | 1.29B | 379.37M | 341.67M | 309.26M |
| Net Income | 732,000 | (117.69M) | (29.66M) | (74.29M) | 103.14M | 86.87M | 101.03M | 28.79M | 68.64M | 63.08M | 44.98M | 26.34M |
| EPS | 0.03 | -4.83 | -1.23 | -3.11 | 4.86 | 4.16 | 4.90 | 1.33 | 3.50 | 3.90 | 2.84 | 1.72 |
| Total Assets | 4.05B | 4.20B | 4.38B | 4.52B | 1.88B | 1.76B | 1.69B | 1.59B | 1.50B | 704.69M | 626.83M | 541.10M |
| Total Debt | 1.39B | 1.64B | 1.70B | 1.73B | 45.05M | 52.70M | 36.26M | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 307.96M | 308.57M | 254.22M | 208.78M | 552.83M | 396.10M | 268.67M | 344.78M | 290.07M | 445.08M | 336.16M | 275.81M |
| Operating Cash Flow | 179.85M | 204.03M | 166.20M | (62.13M) | 267.54M | 222.75M | 101.92M | 160.22M | 154.42M | 89.94M | 54.87M | 60.64M |
| Free Cash Flow | 91.80M | 124.66M | 72.53M | (161.46M) | 186.37M | 122.36M | (4.12M) | 59.44M | 74.74M | 65.39M | 40.93M | 43.05M |
| FCF per Share | 3.73 | 5.11 | 3.01 | -6.76 | 8.79 | 5.85 | -0.20 | 2.75 | 3.81 | 4.04 | 2.58 | 2.82 |
| Book Value | 2.12B | 1.97B | 2.12B | 2.09B | 1.62B | 1.50B | 1.38B | 1.26B | 1.20B | 660.15M | 579.87M | 508.25M |
| Cash & ST Investments | 307.96M | 308.57M | 254.72M | 213.01M | 567.25M | 410.78M | 292.64M | 382.11M | 300.13M | 445.08M | 377.40M | 346.76M |
| ROC Equity | 0.00 | -0.06 | -0.01 | -0.04 | 0.06 | 0.06 | 0.07 | 0.02 | 0.06 | 0.10 | 0.08 | 0.05 |